Duo An

Title: Duo An: Innovator in Cancer Immunotherapy

Introduction

Duo An is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of cancer immunotherapy, particularly in the identification of antigen-specific T cells. His innovative work has led to the development of advanced methodologies that enhance the detection and analysis of T cells, which are crucial for effective cancer treatment.

Latest Patents

Duo An holds 2 patents that focus on compositions and methods for the identification of antigen-specific T cells. His latest patents disclose antigenic peptide-MHC complexes, termed comPACT polypeptides and comPACT polynucleotides. These patents detail methods for producing such complexes and highlight their exemplary use in capturing cancer neoepitope-reactive T cells with high accuracy. Additionally, he has developed dual particle detection approaches that improve the sensitivity and specificity of neoantigen-specific T cell detection. His work also includes signal-to-noise ratio analysis of isolated T cells, which enhances the detection of neoantigen-specific T cells.

Career Highlights

Throughout his career, Duo An has worked with notable companies such as Adoc Ssf, LLC and Pact Pharma, Inc. His experience in these organizations has allowed him to refine his expertise in cancer immunotherapy and contribute to groundbreaking research in the field.

Collaborations

Duo An has collaborated with several professionals in his field, including Songming Peng and Boi Bryant Quach. These collaborations have further enriched his research and development efforts, leading to innovative solutions in cancer treatment.

Conclusion

Duo An's contributions to the field of cancer immunotherapy through his patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for improved cancer treatments and better patient outcomes.